Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Phase 1 dose-escalation trial with 29 enrolled participants testing safety and maximum tolerated dose; no efficacy results reported in this registry record.
This is a Phase 1/2 trial registration with no posted results; it describes a planned early-phase study of a novel combination in a difficult-to-treat cancer.
Phase 1 trial of a three-drug combination in metastatic breast cancer with dose-limiting toxicity as the primary endpoint; no results posted in this registry record.
This is a Phase 2 trial registry record with only 5 enrolled participants and no results posted; it represents early-phase work that requires confirmation.
This is a Phase 2 screening trial registry record with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.